-
公开(公告)号:US20130245002A1
公开(公告)日:2013-09-19
申请号:US13613291
申请日:2012-09-13
申请人: Chao CHEN , Haibing DENG , Haibing GUO , Feng HE , Lei JIANG , Fang LIANG , Yuan MI , Huixin WAN , Yao-Chang XU , Hongping YU , Ji Yue ZHANG
发明人: Chao CHEN , Haibing DENG , Haibing GUO , Feng HE , Lei JIANG , Fang LIANG , Yuan MI , Huixin WAN , Yao-Chang XU , Hongping YU , Ji Yue ZHANG
IPC分类号: C07D471/04 , A61K31/496 , A61K31/5513 , A61K31/5377 , C07D491/107 , A61K45/06 , A61K31/437
CPC分类号: A61K31/551 , A61K31/437 , A61K31/4709 , A61K31/496 , A61K31/5377 , A61K31/5513 , A61K45/06 , C07D471/04 , C07D491/107 , C07D519/00
摘要: The invention relates to compounds of formula (I) and salts thereof: wherein the substituents are as defined in the specification; a compound of formula (I) for use in the treatment of the human or animal body, in particular with regard to c-Met tyrosine kinase mediated diseases or conditions; the use of a compound of formula (I) for manufacturing a medicament for the treatment of such diseases; pharmaceutical compositions comprising a compound of the formula (I), optionally in the presence of a combination partner, and processes for the preparation of a compound of formula (I).